Mitochondrial reactive oxygen species act as autocrine neuromodulators in retinal ganglion cells
Mitochondrial reactive oxygen species act as autocrine neuromodulators in retinal ganglion cells
批准号:
10343744
负责人:
Benjamin Smith
金额:
$7.17万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-02-01 至 2023-01-31
关键词:
Action PotentialsAffectAnimalsAutomobile DrivingAxonBiophysicsBlindnessCell membraneCellsChronicClosure by clampCommunicationConsumptionDataElectrophysiology (science)Energy SupplyEnvironmentEvolutionExpenditureFeedbackFluorescenceFunctional disorderGaussian modelGenerationsGlaucomaGoalsHealthHydrogen PeroxideInjectionsInterventionIon ChannelIon Channel GatingIonsKineticsLabelLightLinkMeasurementMeasuresMediatingMembrane PotentialsMetabolicMetabolismMitochondriaModelingNational Eye InstituteNeurodegenerative DisordersNeuromodulatorNeuronsNeurophysiology - biologic functionNeurotransmittersNoiseOutputOxidantsPhysiologicalPlayPreventionProcessProductionPropertyProtocols documentationReactive Oxygen SpeciesRegulationResearchResearch Project GrantsRestRetinaRetinal DiseasesRetinal Ganglion CellsRiskRoleSignal TransductionStimulusSynapsesTestingTimeVisionVisualautocrinebiophysical propertiescell typecostexperimental studyextracellularfluorescence imagingganglion cellimprovedinsightlight intensityluminanceneuronal excitabilityneuroregulationoptic nerve disorderpatch clamppresynapticpreventresilienceresponsesight restorationskillsstatisticstherapeutic developmenttransmission processvoltagevoltage clamp
中文摘要
项目总结/文摘
英文摘要
Project Summary/Abstract
Neurons continuously maintain ion gradients across their cell membrane in order to facilitate electrical signaling.
ATP produced by the mitochondria is required to re-establish these gradients following the electrical activity
necessary for information transmission. Reactive oxygen species (ROS) are produced as an inevitable
consequence of energy production in the mitochondria. ROS interact with many of the ion channels that control
neuronal excitability however the degree to which ROS modulate neuronal function under normal circumstances
is not clear. While a basal level of ROS is a normal feature of the intracellular milieu, prolonged elevation of ROS
is part of the metabolic dysregulation that appears to be a key factor in optic neuropathies, including glaucoma.
In retinal ganglion cells (RGCs) the rate of action potentials (spikes) produced by a visual scene is strongly
dependent on contrast, the range of light intensities varying around the mean. The retina adapts both to mean
luminance and contrast and reduces sensitivity in response to prolonged high contrast stimuli. The switch
between low and high contrast dramatically increases mean spike rate and consequently metabolic demand.
The primary focus of this research project is to understand how changes in ROS modulate the function of
genetically identified RGCs under normal conditions particularly during the shifts in metabolic demand that occur
during shifts in contrast.
Experiments proposed in Aim 1 will elaborate on preliminary data showing subtype specific modulation of RGC
excitability by elevating or reducing endogenous ROS levels. Experiments will test effects of elevated ROS levels
on excitatory and inhibitory input as well as intrinsic excitability using injected current steps. In Aim 2, I will used
paired, injected current steps as well as Gaussian white noise current injection of either low or high variance to
model states of low or high metabolic demand and determine the contribution of ROS to contrast adaptation.
Finally in Aim 3, I will investigate the underlying biophysics of the interaction of ROS with voltage-gated
conductances measured in nucleated patch recordings from identified RGC subtypes.
Metabolism, adaptation, and resilience to degeneration are fundamental features of neural function therefore
these studies will further our understanding of processes mediating visual function in the retina. This objective is
consistent with the health-related goals of the National Eye Institute for the understanding of retinal circuits and
the development of therapeutic approaches essential for the treatment and prevention of retinal disease.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Mitochondrial reactive oxygen species act as autocrine neuromodulators in retinal ganglion cells
-
批准号:10157645
-
项目类别:
-
资助金额:$6.86万
-
财政年份:2021
-
负责人:Benjamin Smith
-
依托单位:
海外基金